Antimicrobial Resistance Selection

Read the erosion of an antimicrobial's effectiveness as directional selection — the agent's use prunes susceptible organisms and spares pre-existing resistant variants — so a failing protocol reports a shifted population, not a degraded drug, and the user of the agent is the source of the pressure.

Core Idea

Antimicrobial resistance selection is the process by which sustained exposure to an antimicrobial preferentially eliminates susceptible organisms while sparing resistant variants, so resistance rises and the agent's effectiveness erodes. The mechanism is directional Darwinian selection on heritable microbial variation. Two features mark the medicine-specific instance: the user of the agent supplies the selection pressure (every prescription is a selection event), and short microbial generations outrun the 15-20-year discovery pipeline.

Scope of Application

Lives across the infectious-disease and public-health subfields of medicine, by antimicrobial class and care setting; its reach is within that domain.

• Antibacterial stewardship — the home turf: MRSA, carbapenem-resistant Enterobacteriaceae, XDR TB.
• Antifungal resistance — Candida auris and azole-resistant Aspergillus, with agricultural fungicide spillover.
• Antiviral resistance — HIV, HCV, influenza, where cocktails raise the per-mutation fitness cost.
• Antiparasitic resistance — artemisinin-resistant malaria and ivermectin resistance in helminths.
• Public-health policy and surveillance — resistance tracking and the pharmacopoeia-exhaustion framing.

Clarity

Naming the process establishes that resistance is the expected output of selection, not a moral failure. It holds molecular potency (unchanged) distinct from population-level effectiveness (eroded), so a failing protocol reports a changed population, not a degraded drug. Its sharpest move exposes who supplies the pressure — the prescribing population — recasting stewardship as managing a selection regime and prescribing as a commons with an intergenerational externality.

Manages Complexity

Resistance case by case is a sprawling literature of mechanisms, organisms, and protocols. The framing collapses it to one structural object — a variable population, an agent whose action is the selection pressure, a conditional resistance payoff — whose trajectory follows from a few named parameters (pressure strength, per-event fitness cost, mutation-and-transfer rate, resistance-versus-discovery timescale). The same parameters fix a remedy menu, each lever attached to the term it moves.

Abstract Reasoning

The lead move is causal re-attribution: a failing protocol means a shifted composition, not a degraded drug — which is why new chemistry alone only postpones. A predictive move runs directional selection forward from the parameter set to forecast how fast resistance rises and whether a class is losing the race. An interventionist move attaches each lever to the term it moves. Boundary moves identify the user as the pressure source and draw a sharp model-selection line: one-sided directional selection, not red-queen dynamics.

Knowledge Transfer

Within medicine the concept transfers as mechanism — the directional-selection model, the potency-versus-effectiveness diagnostic, and the remedy menu carry intact across antibacterial, antifungal, antiviral, and antiparasitic classes, because the substrate is constant. Population genetics and IPM refuge/rotation strategies transfer literally into the domain. Beyond it the transfer bifurcates: to other biological substrates (pesticide, chemotherapy, vaccine-escape resistance) it is the same mechanism, carried by the parent treatment-induced-selection prime; to adversarial substrates (cybersecurity, fraud) it is only analogy, routed instead to arms_race/red_queen. The prescribing-and-stewardship accent stays home.

Relationships to Other Abstractions

Current abstraction Antimicrobial Resistance Selection Domain-specific

Parents (4) — more general patterns this builds on

• Antimicrobial Resistance Selection is part of, conditional Conjunctive Path Activation Prime

  Under genuinely simultaneous independent combination therapy, escape becomes a conjunctive path that conducts only when resistance to every active mechanism co-occurs in one transmissible lineage.

• Antimicrobial Resistance Selection is part of, conditional Sanctuary Effect Prime

  Resistance selection conditionally contains a Sanctuary Effect when an untreated or sub-inhibitory niche lets variants regenerate beyond effective drug reach and reseed the treated compartment after suppression.

• Antimicrobial Resistance Selection is a decomposition of Natural Selection Prime

  Removing clinical microbiology leaves the exact variation-selection-retention engine: antimicrobial exposure differentially preserves heritable resistant variants and shifts population composition over microbial generations.

• Antimicrobial Resistance Selection is a decomposition of, typical Tragedy of the Commons Prime

  In its ordinary prescribing and agricultural regime, each locally rational use consumes a small part of shared future antimicrobial effectiveness, while the diffuse resistance cost is borne by other users and later generations.

Hierarchy paths (9) — routes to 7 parentless roots

• Antimicrobial Resistance Selection → Conjunctive Path Activation → Causality → Dependency

Show alternative paths (8)

Neighborhood in Abstraction Space

Antimicrobial Resistance Selection sits in a sparse region of the domain-specific corpus (95^th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Pharmacokinetics & Drug Response (19 abstractions)

Nearest neighbors

• Idiosyncratic Reaction — 0.81
• Price Equation — 0.81
• Pharmacodynamic Antagonism — 0.80
• Enemy release hypothesis — 0.80
• Baldwin Effect — 0.80

Computed from structural-signature embeddings · 2026-07-12